Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
XCENA | $135,000,000 | (Jun 2, 2026)
MerQube
United States
- San Francisco, CA
- 14/07/2023
- Series B
- $22,000,000
MerQube is an innovative fintech firm, leading the development of cutting edge technology for indexing and rules-based investing. MerQube offers design and calculation solutions for complex rules-based strategies. Launched in 2019 in New York and San Francisco by a team of index industry veterans and technology experts, MerQube was created to provide technology focused alternative.
MerQube designs and calculates a wide variety of indices, ranging from thematic to ESG, factor and retirement, while covering multi-asset, equities, futures as well as options. Leveraging cloud-based architecture and today's most advanced index-tracking technology, MerQube's platform enables its clients to bring ideas to market quickly and efficiently.
- Industry Capital Markets
- Website https://merqube.com/
- LinkedIn https://www.linkedin.com/company/merqube/
Related People
Vinit SrivastavaCo Founder
United States -
New York, New York,
Vinit is the co-founder and CEO of MerQube, an innovative index provider. Prior to launching MerQube in 2021, Vinit was Managing Director at S&P Dow Jones Indices, where he acted as Global Head of Strategy, Volatility, and ESG Indices Product Management. Before his nine years in the S&P Global group, Vinit was a Principal Engineer at Oracle, where he managed development teams working on enterprise applications and infrastructure software products.
Gray Swan | $40,000,000 | (Jun 2, 2026)
Countable Labs | $26,000,000 | (May 29, 2026)
Rep AI | $6,200,000 | (May 29, 2026)
Psilera | $8,800,000 | (May 29, 2026)
Reactor | $59,000,000 | (May 29, 2026)
MokN | $15,000,000 | (May 29, 2026)
Crimson | $2,500,000 | (May 29, 2026)
Kubera Health | $6,500,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)